Literature DB >> 1903948

Dihydroisoquinolinones: the design and synthesis of a new series of potent inhibitors of poly(ADP-ribose) polymerase.

M J Suto1, W R Turner, C M Arundel-Suto, L M Werbel, J S Sebolt-Leopold.   

Abstract

A series of dihydroisoquinolinones, formally rigid analogs of 3-substituted benzamides, and a series of 2,3-disubstituted benzamides were synthesized and evaluated as inhibitors of poly(ADP-ribose) polymerase. The results indicated that the orientation of the amide with respect to the substituent on the aromatic ring was critical for optimum inhibitory activity. Selected compounds were also evaluated for their ability to modify the radiation response of mammalian cells to ionizing radiation. A number of the 5-substituted dihydroisoquinolinones, which were very potent inhibitors of the enzyme, were able to enhance the lethal effects of ionizing radiation in mammalian cells, as measured by changes in the survival curve parameters Do and/or Dq.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903948

Source DB:  PubMed          Journal:  Anticancer Drug Des        ISSN: 0266-9536


  25 in total

Review 1.  Hypersensitivity phenotypes associated with genetic and synthetic inhibitor-induced base excision repair deficiency.

Authors:  Julie K Horton; Samuel H Wilson
Journal:  DNA Repair (Amst)       Date:  2006-11-20

2.  Structure of the catalytic fragment of poly(AD-ribose) polymerase from chicken.

Authors:  A Ruf; J Mennissier de Murcia; G de Murcia; G E Schulz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

3.  5-Aminoisoquinolinone reduces colon injury by experimental colitis.

Authors:  Salvatore Cuzzocrea; Emanuela Mazzon; Rosanna Di Paola; Tiziana Genovese; Nimesh S A Patel; Carmelo Muià; Michael D Threadgill; Angelina De Sarro; Christoph Thiemermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-11-18       Impact factor: 3.000

4.  Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations.

Authors:  Conrad C Alano; Tiina M Kauppinen; Andreu Viader Valls; Raymond A Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

5.  Poly(ADP-ribose) contributes to an association between poly(ADP-ribose) polymerase-1 and xeroderma pigmentosum complementation group A in nucleotide excision repair.

Authors:  Brenee S King; Karen L Cooper; Ke Jian Liu; Laurie G Hudson
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

Review 6.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

Review 7.  Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

Authors:  N J Curtin
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

8.  Editor's Highlight: Interactive Genotoxicity Induced by Environmentally Relevant Concentrations of Benzo(a)Pyrene Metabolites and Arsenite in Mouse Thymus Cells.

Authors:  Huan Xu; Fredine T Lauer; Ke Jian Liu; Laurie G Hudson; Scott W Burchiel
Journal:  Toxicol Sci       Date:  2016-08-07       Impact factor: 4.849

Review 9.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

10.  Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.

Authors:  Mauricio F Farez; Francisco J Quintana; Roopali Gandhi; Guillermo Izquierdo; Miguel Lucas; Howard L Weiner
Journal:  Nat Immunol       Date:  2009-08-16       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.